The use of FDG-PET in assessing axillary lymph node status in breast cancer: a systematic review and meta-analysis of the literature.
about
Local treatment of the axilla in early breast cancer: concepts from the national surgical adjuvant breast and bowel project B-04 to the planned intergroup sentinel mamma trial(18)F-FDG PET/CT Findings in a Breast Cancer Patient with Concomitant Tuberculous Axillary Lymphadenitis.Positron Emission Tomography (PET) in OncologyMetabolic positron emission tomography imaging in cancer detection and therapy response.Accurate diagnosis of axillary lymph node metastasis using contrast-enhanced ultrasonography with Sonazoid.Accurate evaluation of axillary sentinel lymph node metastasis using contrast-enhanced ultrasonography with Sonazoid in breast cancer: a preliminary clinical trialMolecular Imaging in Breast Cancer: From Whole-Body PET/CT to Dedicated Breast PET.Feasibility of sentinel lymph node biopsy in breast cancer patients clinically suspected of axillary lymph node metastasis on preoperative imaging.The application of PET-CT to post-mastectomy regional radiation therapy using a deformable image registrationAccuracy of axillary ultrasound in preoperative nodal staging of breast cancer - size of metastases as limiting factor.The Comparative Study of Ultrasonography, Contrast-Enhanced MRI, and (18)F-FDG PET/CT for Detecting Axillary Lymph Node Metastasis in T1 Breast Cancer.Assessment of Ultrasound Features Predicting Axillary Nodal Metastasis in Breast Cancer: The Impact of Cortical ThicknessDefining the role of modern imaging techniques in assessing lymph nodes for metastasis in cancer: evolving contribution of PET in this setting.Axillary lymph node dissection in early-stage invasive breast cancer: is it still standard today?Accuracy of predicting axillary lymph node positivity by physical examination, mammography, ultrasonography, and magnetic resonance imaging.Is imaging the future of axillary staging in breast cancer?Optical techniques for the intraoperative assessment of nodal status.Clinical application of 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in breast cancer.Nodal status assessment in breast cancer: strategies of clinical grounds and quality of life implications.Can We Skip Intraoperative Evaluation of Sentinel Lymph Nodes? - Nomogram Predicting Involvement of Three or More Axillary Lymph Nodes Before Breast Cancer Surgery.Correlation between 18F-FDG Positron-Emission Tomography 18F-FDG Uptake Levels at Diagnosis and Histopathologic and Immunohistochemical Factors in Patients with Breast Cancer.Accuracy of 18F-FDG PET/CT for primary tumor visualization and staging in T1 breast cancer.What is the future of magnetic nanoparticles in the axillary management of breast cancer?Clinical significance of FDG-PET/CT at the postoperative surveillance in the breast cancer patients.Role of diffusion-weighted MRI: predicting axillary lymph node metastases in breast cancer.Semi-quantitative lymph node assessment of (18)F-FDG PET/CT in locally advanced breast cancer: correlation with biological prognostic factors.Locoregional lymph node involvement on 18F-FDG PET/CT in breast cancer patients scheduled for neoadjuvant chemotherapy.Diagnostic and prognostic correlates of preoperative FDG PET for breast cancer.Amino Acid Metabolism as a Target for Breast Cancer Imaging
P2860
Q33684856-C43CCB93-559D-43FB-9B07-D61EC545B725Q33704463-D9A72465-0345-46FD-AA1D-A868E632A56CQ34774840-500016D5-0029-44E6-B455-CC138404ECD9Q34786518-2DD2EE55-46FA-4688-BB51-FDA2BA0FF361Q35179879-EC0A34CB-CF2B-43BC-AE25-FD6C3303A1ADQ36070712-47769F59-BD3F-4240-BDA5-5A8C84050720Q36104568-BA85C157-AE80-4538-A8A3-F6D036019853Q36874090-F2E5799F-5E42-43B1-A56A-40C1A2A9535EQ36972681-17DA3F53-9A0F-4B45-BFCC-86FA32DB1456Q37068966-37D07045-F9CE-43FE-93C2-31AABBAB4563Q37240056-CD95E829-8412-4F7E-BFCA-F61D52E2B7ECQ37255865-77494A6C-09C4-4060-9DC8-5C9EA9C41949Q37827751-BC794173-370A-40EA-B80A-65342CF5FD2DQ37869394-09CF25EE-0DC6-4D65-842A-D70E45003048Q37974082-2D72C4C0-5E58-482A-8192-7C96E2C1E49EQ38137722-F85BFEDC-CAC8-4984-A29B-01F510DA09F5Q38155204-C92B3721-52F4-4928-B9AA-99F26B03FA59Q38165388-1CC48355-34E0-49A6-A1A8-336253739820Q38199690-9D2426BB-4E43-43E8-B817-44A2BBC5EA02Q38406046-389B1B9A-339B-4689-A014-672B1ACA9EDDQ42102903-34738DD8-4372-4C0A-BBA6-D0B7CDBDDB60Q44456340-90105457-20CD-4E22-882B-066EA4C09522Q51328839-DF26E5DB-2AA4-4510-9072-5CFA9EF30C27Q53064540-192D4810-316D-4402-9E1A-ECFEF65926A9Q53088793-7EF3AB9E-0BD6-41FA-A4DE-C282F3096C6BQ53137602-49943773-6115-4921-8A17-1602F8C4AC13Q53148285-FA563784-E71A-4982-A0F4-B62879C05AF1Q53153075-EB3CFB22-6456-43A2-B7F9-3140179F00CFQ57110643-B598B1AC-C850-4492-B933-27C24D57951D
P2860
The use of FDG-PET in assessing axillary lymph node status in breast cancer: a systematic review and meta-analysis of the literature.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The use of FDG-PET in assessin ...... ta-analysis of the literature.
@en
The use of FDG-PET in assessin ...... ta-analysis of the literature.
@nl
type
label
The use of FDG-PET in assessin ...... ta-analysis of the literature.
@en
The use of FDG-PET in assessin ...... ta-analysis of the literature.
@nl
prefLabel
The use of FDG-PET in assessin ...... ta-analysis of the literature.
@en
The use of FDG-PET in assessin ...... ta-analysis of the literature.
@nl
P1476
The use of FDG-PET in assessin ...... eta-analysis of the literature
@en
P2093
Rebecca Peare
P2860
P2888
P304
P356
10.1007/S10549-010-0771-9
P407
P577
2010-02-07T00:00:00Z